EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Characterization of Tritium‐Labeled Neuropeptide Y Y 5 Receptor Ligands Derived From CGP71683A

Franziska Schettler, Pierre Koch iD, Max Keller iD

Archiv der Pharmazie · 2026-08 · 359 (8)

DOI: 10.1002/ardp.70314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 17.08.2026. Verfasst von Franziska Schettler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Receptors, Neuropeptide Y. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the human neuropeptide Y (NPY) receptors, the Y 5 receptor (Y 5 R) represents a potential therapeutic target for the treatment of obesity and stress‐related diseases. As the Y 5 R is expressed in various malignant tumors, it is also considered a potential target for cancer diagnosis and therapy. Although numerous non‐peptidic Y 5 R antagonists with high binding affinity have been reported, only labeled peptidic agonists are used in routine Y 5 R competition binding assays, which are needed for the development and characterization of Y 5 R ligands. In the present study, three radiolabeled derivatives of the high‐affinity Y 5 R antagonist CGP71683A ( 1 ) were synthesized ([ 3 H] 26 , [ 3 H] 32 , [ 3 H] 42 ) and studied in saturation binding assays using adherent or suspended HEC‐1B‐hY 5 R cells or membrane preparations thereof. Their K d values (1.5–13 nM) were consistent with the K i values (1.3–11 nM) of the non‐labeled analogs. However, all synthesized radioligands exhibited very high non‐specific binding, primarily caused by binding of the radioligands to cellular membranes, which limits their use as tool compounds in radiochemical Y 5 R binding assays. Nevertheless, a competition binding assay with [ 3 H] 32 and the endogenous Y 5 R agonist hNPY afforded a K i that was in agreement with literature data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Neuropeptide YLigandsHumansRadioligand AssayTritiumBinding, CompetitiveStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

Y5 receptorbinding assayneuropeptide Yradioligand

Substanzen

Receptors, Neuropeptide YLigandsneuropeptide Y5 receptorTritium

Autor:innen und Institutionen

  • Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Regensburg, Germany.

ORCID-Profile: Pierre Koch, Max Keller

Zitieren

APA

Schettler, F., Koch, P., & Keller, M. (2026). Synthesis and Characterization of Tritium‐Labeled Neuropeptide Y Y 5 Receptor Ligands Derived From CGP71683A. Archiv der Pharmazie, 359(8). https://doi.org/10.1002/ardp.70314

Vancouver

Schettler F, Koch P, Keller M. Synthesis and Characterization of Tritium‐Labeled Neuropeptide Y Y 5 Receptor Ligands Derived From CGP71683A. Archiv der Pharmazie. 2026;359(8). doi:10.1002/ardp.70314

BibTeX
@article{Schettler2026,
  author = {Schettler, Franziska and Koch, Pierre and Keller, Max},
  title = {Synthesis and Characterization of Tritium‐Labeled Neuropeptide Y Y 5 Receptor Ligands Derived From CGP71683A},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {8},
  doi = {10.1002/ardp.70314}
}
Kostenlos starten →